Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen dose escalation and endoxifen levels in CYP2D6 poor metabolizers with hormone-sensitive breast cancer
2007-002942-40Phase 4Active
- Sponsor
- Hospital Provincial de Castellón
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tamoxifen in breast cancer (4 arms), sponsored by Hospital Provincial de Castellón. Primary endpoint: Comparison of plasma concentrations of endoxifen. Started Sep 2007; status: active.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2007-002942-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002942-40.